Barrack, Rodos & Bacine Files Stockholder's Derivative Complaint on behalf of Pfizer, Inc.

9/30/2009 - Barrack, Rodos & Bacine filed a stockholder’s derivative action on behalf of pharmaceutical manufacturer Pfizer, Inc. alleging that its past and present directors and senior officers harmed the company by causing it to illegally market 13 prescription drugs over many years. Pfizer was fined $2.3 billion for its illegal conduct, the company’s fourth multi-million dollar fine since 2002. The derivative complaint also alleges that the Pfizer directors solicited proxies without disclosing their involvement in the conduct that resulted in the fine. If you would like to learn more about this action or if you wish to discuss the matter further, please contact BR&B partner A. Arnold Gershon by telephone at (212) 688-0782, or by email at agershon@barrack.com.